Fairmount Funds Management’s Neurogene NGNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,637	Closed	-$4.47M	–	20
2020 Q3	$4.47M	Sell	18,637 -19,867	-52%	-$4.77M	1.89%	15
2020 Q2	$12.8M	Sell	38,504 -2,000	-5%	-$664K	5.7%	8
2020 Q1	$9.22M	Hold	40,504	–	–	5.59%	9
2019 Q4	$9.98M	Buy	+40,504	New	+$9.98M	6.05%	9